b**u
发帖数: 2761 | 1 【 以下文字转载自 Missouri 讨论区 】
发信人: Geisha (朔风如解意 容易莫摧残), 信区: Missouri
标 题: zz Amgen to Buy Onyx for $10.4 Billion
发信站: BBS 未名空间站 (Mon Aug 26 12:22:52 2013, 美东)
Although Amgen is the world’s biggest biotechnology company, the drug maker
has been mostly absent from one of the industry’s biggest and fastest-
growing markets: cancer drugs.
It took a big step to fix that on Sunday, agreeing to buy Onyx
Pharmaceuticals for about $10.4 billion in cash to gain access to the
company’s three anticancer treatm... 阅读全帖 |
|
d****n
发帖数: 30 | 2 帮朋友在美国找人才，朋友说是年薪百万的工作。有兴趣的请联系我： docsun@163.
com
来信的subject请写上申请工作的具体位置。祝好运！
请勿站内联系。
Company Profile: 国内排名前列新药、原料药研发集团； 美国上市企业
工作一：Executive Director
工作二：Chemical Engineering Director
工作一：Executive Director
Position: Executive Director
Location :Shanghai,China
Department: Process Research Development (PRD)
Direct Report Line: VP
Subordinate: Director I&II Associate Director I&II Assistant Director
Group Leader I&II
Major Responsibilities: I Projects
1. Manage all projects of responsible de... 阅读全帖 |
|
发帖数: 1 | 3 A clinical SAS training will start in the first week of December! This on-
line training is delicately designed for anyone who has strong desire to
work for a major Pharmaceutical company in US as a qualified SAS programmer,
and include two sessions: two-month regular session and one-month project
session.
The training provides comprehensive knowledge of: clinical trials, CDISC
standards (SDTM, ADaM), Pinnacle 21, and SAS skills: basic data steps, Proc
SQL, and Macros applied in pharmaceutical i... 阅读全帖 |
|
d**********0
发帖数: 222 | 4 【 以下文字转载自 Pharmaceutical 讨论区 】
发信人: datamining10 (挖土机), 信区: Pharmaceutical
标 题: diploma的问题
发信站: BBS 未名空间站 (Thu Jul 17 14:17:22 2008)
小秘告诉我，Ph.D的diploma上可以写 Pharmaceutical Science OR Pharmaceutical &
Pharmacological Sciences. 让我选。给位觉得哪一个好，从将来找工作，申请Ｈ1－
Ｂ，找工作的角度来看。谢谢。 |
|
a*******e
发帖数: 412 | 5 Faculty Positions Available
Department of Pharmacology and Pharmaceutical Sciences, Tsinghua University,
Beijing, China
The Department of Pharmacology and Pharmaceutical Sciences is actively
seeking candidates for tenure track faculty positions at all levels. We seek
outstanding individuals to develop and conduct innovative basic and/or
translational research in areas of including but not limited to 1)
quantitative molecular and systems pharmacology, pharmacogenomics, drug
development sciences, ... 阅读全帖 |
|
发帖数: 1 | 6 A clinical SAS training will start in the first week of December! This on-
line training is delicately designed for anyone who has strong desire to
work for a major Pharmaceutical company in US as a qualified SAS programmer,
and include two sessions: two-month regular session and one-month project
session.
The training provides comprehensive knowledge of: clinical trials, CDISC
standards (SDTM, ADaM), Pinnacle 21, and SAS skills: basic data steps, Proc
SQL, and Macros applied in pharmaceutical i... 阅读全帖 |
|
w*****1
发帖数: 220 | 7 Dear Readers,
We are happy to present the first five papers that are published in our
new, open access journal, Physical Review X. These papers, together with
others that are to be published in the coming weeks into September, will
constitute the first issue of the journal. Under PRX's open access
publishing model, they are free for you to read and use.
We are very encouraged by the breadth of their topical spread. It ranges
from the well-established field of atomic, molecular and optica... 阅读全帖 |
|
k****n
发帖数: 98 | 8 【 以下文字转载自 JobHunting 讨论区 】
发信人: kaixin (胖子), 信区: JobHunting
标 题: A Statistical Consultant Opening in NY/NJ Area, to be filled soon
发信站: BBS 未名空间站 (Fri Aug 30 15:16:48 2013, 美东)
Please contact through mitbbs
============================================================================
=================
A full – time statistical consultant position in a major Pharmaceutical
company manufacturing site
Responsibilities:
The person will provide statistical assessments and develop models for drug
manu... 阅读全帖 |
|
s******g
发帖数: 193 | 9 If interested, PM me and I'll let you know my email address.
---------------------
We plan to hire an “Economic Consultant, Life Sciences” that starts in
mid July. This position will report to me. Ideally we are looking for
someone with PhD in a quantitative field such as statistics, biostatistics,
or epidemiology. Prior working experience in health economics,
pharmaceutical pricing and reimbursement, modeling and simulation, or
healthcare database analysis is a plus but not required.
The empha... 阅读全帖 |
|
发帖数: 1 | 10 This two-month on-line training (March & April) is delicately designed for
anyone who has strong desire to work for a major Pharmaceutical company in
US as a qualified SAS programmer.
This training is a comprehensive combination of clinical knowledge: clinical
trials, CDISC standards (SDTM, ADaM), Pinnacle 21, and SAS knowledge: SAS
data steps, Proc SQL, and Macro etc. required in pharmaceutical industry, in
addition to statistical knowledge applied in clinical data analysis,
towards creation of... 阅读全帖 |
|
发帖数: 1 | 11 This two-month on-line training (March & April) is delicately designed for
anyone who has strong desire to work for a major Pharmaceutical company in
US as a qualified SAS programmer.
This training is a comprehensive combination of clinical knowledge: clinical
trials, CDISC standards (SDTM, ADaM), Pinnacle 21, and SAS knowledge: SAS
data steps, Proc SQL, and Macro etc. required in pharmaceutical industry, in
addition to statistical knowledge applied in clinical data analysis,
towards creation of... 阅读全帖 |
|
发帖数: 1 | 12 This two-month on-line training (June & July) is delicately designed for
anyone who has strong desire to work for a major Pharmaceutical company in
US as a qualified SAS programmer. Target salary: $100K.
This training is a comprehensive combination of clinical knowledge: clinical
trials, CDISC standards (SDTM, ADaM), Pinnacle 21, and SAS knowledge: SAS
data steps, Proc SQL, and Macro etc. required in pharmaceutical industry, in
addition to statistical knowledge applied in clinical data analysis,... 阅读全帖 |
|
发帖数: 1 | 13 This two-month on-line training (September & October) is delicately designed
for anyone who has strong desire to work for a major Pharmaceutical company
in US as a qualified SAS programmer. Target salary: $100K.
This training is a comprehensive combination of clinical knowledge: clinical
trials, CDISC standards (SDTM, ADaM), Pinnacle 21, and SAS knowledge: SAS
data steps, Proc SQL, and Macro etc. required in pharmaceutical industry, in
addition to statistical knowledge applied in clinical data a... 阅读全帖 |
|
发帖数: 1 | 14 This two-month on-line training (September & October) is delicately designed
for anyone who has strong desire to work for a major Pharmaceutical company
in US as a qualified SAS programmer. Target salary: $100K.
This training is a comprehensive combination of clinical knowledge: clinical
trials, CDISC standards (SDTM, ADaM), Pinnacle 21, and SAS knowledge: SAS
data steps, Proc SQL, and Macro etc. required in pharmaceutical industry, in
addition to statistical knowledge applied in clinical data a... 阅读全帖 |
|
发帖数: 1 | 15 A clinical SAS training will start in the first week of December! This on-
line training is delicately designed for anyone who has strong desire to
work for a major Pharmaceutical company in US as a qualified SAS programmer,
and include two sessions: two-month regular session and one-month project
session.
The training provides comprehensive knowledge of: clinical trials, CDISC
standards (SDTM, ADaM), Pinnacle 21, and SAS skills: basic data steps, Proc
SQL, and Macros applied in pharmaceutical i... 阅读全帖 |
|
发帖数: 1 | 16 This two-month on-line training (September & October) is delicately designed
for anyone who has strong desire to work for a major Pharmaceutical company
in US as a qualified SAS programmer. Target salary: $100K.
This training is a comprehensive combination of clinical knowledge: clinical
trials, CDISC standards (SDTM, ADaM), Pinnacle 21, and SAS knowledge: SAS
data steps, Proc SQL, and Macro etc. required in pharmaceutical industry, in
addition to statistical knowledge applied in clinical data a... 阅读全帖 |
|
s*********e
发帖数: 884 | 17 (This article is a bit old but I think the trend still persists..)
source:
http://trade.gov/press/publications/newsletters/ita_0608/china_
Chinese Health Care Market Is Focus of U.S. Trade Mission
At a time when China is about to undertake major reforms to its health
care system, 15 U.S. companies spent three days in Beijing this past
April to meet with senior officials and to explore commercial
opportunities.
by John Ward
On April 23–25, 2008, Christopher A. Padilla, under secretary of
commerce... 阅读全帖 |
|
s**********8
发帖数: 25265 | 18 Sterilization (microbiology)
http://en.wikipedia.org/wiki/Sterilization_(microbiology)
From Wikipedia, the free encyclopediaJump to: navigation, search This
article has multiple issues. Please help improve it or discuss these issues
on the talk page.
It may need reorganization to meet Wikipedia's quality standards. Tagged
since March 2008.
It is in need of attention from an expert on the subject. WikiProject
Microbiology may be able to help recruit one. Tagged since December 2010.
Contents [hide... 阅读全帖 |
|
a*i
发帖数: 1652 | 19 http://247wallst.com/2011/07/18/the-eleven-most-implanted-medic
11. Implantable Cardioverter Defibrillators
> Number of procedures: 133,262
> Total annual expenditure: $5.5 billion
> Average cost per procedure: $40,000
> Major manufacturer: Medtronic (40%), St. Jude Medical, and Boston
Scientific
Cardiac arrhythmia, or improper electric signaling in the heart, occurs in
millions of people a year. While the vast majority are benign, a select few
— usually in patients with a history of heart attac... 阅读全帖 |
|
A*****8
发帖数: 8590 | 20 Report Information:
Publication date: 11/07/2012
Number of Pages: 145
Report Details:
In 2011, the medical device market worldwide was worth $309bn, with high
single-digit growth from the year before . Despite being a vast and mature
market, there are number of sectors likely to experience fast growth during
the next 10 years. Much of this growth is linked to the prevalence of a
number of diseases worldwide, as well as an aging population. The rise in
neurological disorders will drive both the d... 阅读全帖 |
|
b*******s
发帖数: 5216 | 21 【 以下文字转载自 Returnee 讨论区 】
发信人: KingOfLunHui (轮回之王), 信区: Returnee
标 题: 恒瑞医药上海研究中心诚聘 (转载)
发信站: BBS 未名空间站 (Wed Oct 9 19:41:31 2013, 美东)
发信人: infiniti9 (helix), 信区: Pharmaceutical
标 题: 恒瑞医药上海研究中心诚聘
发信站: BBS 未名空间站 (Wed Jul 11 18:35:45 2012, 美东)
Jiangsu Hengrui Medicine （恒瑞医药） is a leading innovative pharmaceutical
company in China with annual sales of 4.55 billion Chinese Yuan in 2011 and
is poised to continue its growth in coming years. Under the leadership of
successful and experienced scientists... 阅读全帖 |
|
A*******s
发帖数: 9638 | 22 THE SUNSHINE ACT
I confess! I did it! I ate lunch with a representative from a
pharmaceutical company (drug rep). Yes, I confess, most days of the week I
eat lunch with drug reps. I take 15 minutes between patients to sit and eat
and listen. Drug reps provide the lunch. They teach me about their newest
products, both the risks and benefits of their medications.
In an effort to disparage my profession, the government has passed the
Sunshine Act. They are going to publish, on the internet, ... 阅读全帖 |
|
d****n
发帖数: 30 | 23 帮朋友在美国找人才，朋友说是年薪百万的工作。有兴趣的请联系我： docsun@163.
com
来信的subject请写上申请工作的具体位置。祝好运！
请勿站内联系。
Company Profile: 国内排名前列新药、原料药研发集团； 美国上市企业
工作一：Executive Director
工作二：Chemical Engineering Director
工作一：Executive Director
Position: Executive Director
Location :Shanghai,China
Department: Process Research Development (PRD)
Direct Report Line: VP
Subordinate: Director I&II Associate Director I&II Assistant Director
Group Leader I&II
Major Responsibilities: I Projects
1. Manage all projects of responsible de... 阅读全帖 |
|
d****n
发帖数: 30 | 24 帮朋友在美国找人才，朋友说是年薪百万的工作。有兴趣的请联系我： docsun@163.
com
来信的subject请写上申请工作的具体位置。祝好运！
请勿站内联系。
Company Profile: 国内排名前列新药、原料药研发集团； 美国上市企业
工作一：Executive Director
工作二：Chemical Engineering Director
工作一：Executive Director
Position: Executive Director
Location :Shanghai,China
Department: Process Research Development (PRD)
Direct Report Line: VP
Subordinate: Director I&II Associate Director I&II Assistant Director
Group Leader I&II
Major Responsibilities: I Projects
1. Manage all projects of responsible de... 阅读全帖 |
|
j*****7
发帖数: 4348 | 25 From cholesterol fighters to asthma relief, these treatments could earn Big
Pharma $170 billion
By Mike Tarsala | 24/7 Wall St.
Jul 22, 2009 | Updated: 12:29 p.m. ET Jul 22, 2009
Safety and efficacy data are critical to drug candidates. But what really
makes a potential drug attractive is strong top-line data, a new biotech-
based treatment, and a massive potential market.
With help from Thomson Reuters' SD Pharma database and our own backlog of
coverage, BioHealthInvestor.com, a 247wallst.com ... 阅读全帖 |
|
h****r
发帖数: 2056 | 26 Written by M.E.Garza
Tuesday, 01 September 2009 22:22
That certainly seems to be case after the company released big news on
Monday. According to the Maryland based company, Phase II clinical trials
of its seasonal influenza virus-like particle vaccine showed the vaccine was
well tolerated and worked well against three types of seasonal flu,
including H1N1.
There are several reasons why this is an important development for the
company, but there is a more daunting reason why this is big news... 阅读全帖 |
|
|
t*******o
发帖数: 1464 | 28 我考，跌回我几天前捶胸顿足出手的价格了...
Rexahn Pharmaceuticals Announces Phase IIa Study Results of Serdaxin in
Major Depressive Disorder (MDD)
Statistical Significance Achieved on MADRS Change From Baseline (p<0.041) in
Subgroup Analysis of Severe Patients
NEW YORK, Apr 13, 2010 (GlobeNewswire via COMTEX) -- Rexahn Pharmaceuticals,
Inc. /quotes/comstock/14*!rnn/quotes/nls/rnn (RNN 1.88, -1.77, -48.49%) , a
clinical stage pharmaceutical company developing potential best in class
oncology and central nervous syst... 阅读全帖 |
|
y*****l
发帖数: 5997 | 29 来自主题: _pennystock版 - SOMX Somaxon Pharmaceuticals ($4.44, +$1.07, +31.75%) said part of Procter &
Gamble Co.'s (PG, $59.59, -$0.07, -0.12%) sales force will help sell the
drug developer's Silenor insomnia treatment to certain doctors.
Somaxon Pharmaceuticals' Shares Surge 31% On Co-Promo Deal With Procter &
Gamble (PG,SOMX)
Wednesday 08/25/2010 8:18 AM ET - Comtex Smartrend(r)
Related Companies
Symbol Last %Chg
PG 59.48 -0.30%
SOMX 5.11 51.63%
As of 10:41 AM ET 8/25/10
8/25/2010-Shares of Somaxon Pharmaceuticals (NASDAQ:... 阅读全帖 |
|
S***a
发帖数: 1072 | 30 September's BioPharma Catalyst Calendar
By Lisa LaMotta Sep 01, 2010 2:40 pm
This month could be full of opportunities for biotech and pharmaceutical
investors who know where to look.
•More by Lisa LaMotta
•Forest Faces a Positive-Leaning PanelOrexigen Fattens Its Coffers
With Takeda CashSeptember's BioPharma Catalyst CalendarWhat's the Buzz?
30 top traders on these stocks and more
VVUS 6.33 +0.61 (+10.75%)
FRX 29.20 +1.55 (+5.61%)
CBST 22.52 -0.09 (-0.40%)
... 阅读全帖 |
|
y*****l
发帖数: 5997 | 31 Date Company Name Ticker Drug Event Outcome Details
04/30/2011 GlaxoSmithKline PLC GSK, GSK.L Lamictal-XR (sNDA) FDA
decision on Lamictal-XR for conversion to monotherapy for treatment of
partial seizures FDA approved Lamictal XR for conversion to monotherapy
for treatment of partial seizures on Apr.25
-Drug Status
-Approved in Other Countries
04/29/2011 Spectrum Pharmaceuticals Inc SPPI Fusilev (sNDA) FDA
action on Fusilev for additional use in c... 阅读全帖 |
|
f**********g
发帖数: 2252 | 32 Investors Hopeful for Blockbusters From BioSante and Sunesis
1 hours 15 minutes ago - Marketwire via Comtex
MarketwireRecent studies have shown that the chances of FDA approval for
early stage drugs is dropping significantly. Although it remains an exciting
time in the biotech sector with several potential blockbusters working
their way through the regulatory process, now, more than ever, many analysts
are urging investors to use caution. The Bedford Report examines the
outlook for companies in ... 阅读全帖 |
|
K********g
发帖数: 9389 | 33 【 以下文字转载自 Stock 讨论区 】
发信人: KeepBuying (雁过留声), 信区: Stock
标 题: 2011年11月-2012年1月的FDA的NDA医药股
发信站: BBS 未名空间站 (Wed Nov 2 00:25:56 2011, 美东)
既然成为板斧了，那就为股版添点东西。
下面的医药股是2011年11-2012年1月的FDA的NDA待审批的。大家记住，任何药股的NDA
风险都比较大，要学会炒药股，切忌去赌药股的NDA.下面带星号的我觉得还可以值得研
究。
12/8/2011 Antares Pharma Inc. AIS Anturol Gel (NDA) FDA decision
on Anturol Gel for overactive bladder
12/7/2011 AFFYMAX INC AFFY Peginesatide (NDA) FDA panel to
review Peginesatide for anemia associated with chronic... 阅读全帖 |
|
|
W********g
发帖数: 610 | 35 06/29/2012 Astellas Pharma Inc. ALPMY.PK, ALPMF.PK Mirabegron (NDA) FDA
decision on Mirabegron for proposed treatment of overactive bladder
-News
06/28/2012 Bristol-Myers Squibb Co. BMY ELIQUIS (NDA) FDA decision on
ELIQUIS for prevention of stroke and systemic embolism in patients with
atrial fibrillation
06/27/2012 Arena Pharmaceutical Inc. ARNA Lorcaserin (NDA) FDA decision on
Lorcaserin for proposed treatment of obesity
06/21/2012 Repligen Corp RGEN SecreFlo... 阅读全帖 |
|
g******o
发帖数: 33 | 36 中国的法官太二了，看看烙印怎么玩的。
Cipla launched a generic version of valganciclovir in 2008 while the anti-
viral was under patent in India
The Indian Patent Office has reversed an earlier decision granting patent
rights to an anti-viral drug valganciclovir marketed by Roche.
Valganciclovir is used for the treatment of active cytomegalovirus (CMV)
retinitis that occur in people living with HIV.
The Indian Patent Office at Chennai, in a decision released on April 30,
2010, has set aside the patent granted to ... 阅读全帖 |
|
s********s
发帖数: 579 | 37 【 以下文字转载自 Pharmaceutical 讨论区 】
发信人: smileashes (Pb), 信区: Pharmaceutical
标 题: 能干翻日本人的只有印度大哥了Daiichi Sankyo撤了
发信站: BBS 未名空间站 (Mon Apr 7 22:16:18 2014, 美东)
日本人终于收不了Ranbaxy了，把它卖给了一个印度企业Sun Pharma
Sun Pharmaceutical announced Monday a definitive agreement to acquire
Ranbaxy Laboratories under an all-share deal valued at approximately $3.2
billion. Daiichi Sankyo, which currently owns 63.4 percent of Ranbaxy, has
agreed to back the transaction and will hold an about 9 percent stake in the
merged com... 阅读全帖 |
|
m**********e
发帖数: 12525 | 38 因为你智商不行，把medicine和pharmaceutical science搞混了
在美帝英语语境中，medicine一般指internal medicine,一般指内科学，
去药厂的都是pharmaceutical science,
你说得额wisconsin kentucky都是pharmaceutical牛校 |
|
发帖数: 1 | 39 美国familiy中位数也就是5，6万。医生中位数要到20以上。5倍的差距。
提供发达国最差的服务。
美国医疗吸血能力仅次于墙街。
但是，墙街全世界吸血。 医疗可就只吸国内的血。
还有就是保险公司和医院医生狼狈为奸。
The richest year was 2015, when 70 health care CEOs collectively made $2
billion. That was an average of about $28.5 million per CEO and a median of
about $17.3 million per CEO. The median household income in 2015 was $56,515
, which the average health care CEO made in less than a day.2017年7月24日
he sky-high pay of health care CEOs
The CEOs of 70 of the largest U.S. health care companies c... 阅读全帖 |
|
s********i
发帖数: 17328 | 40 先把数字搞搞清啊！
其中，损失最严重的是Amneal Pharmaceuticals和Seadrill Opera(10.14, 0.37,
3.79%)ting。数据显示，Amneal Pharmaceuticals有270亿美元的贷款在2025年到期，
但其价值缩水了80%。Seadrill Operating有260亿美元在2021年到期，但只能拿回面值
的53%。此外，Deluxe集团也在一笔留置权贷款中损失了6亿多美元。
The companies range across sectors, from energy to health care to
communications. The biggest losers as of Tuesday included Amneal
Pharmaceuticals LLC, whose $2.7 billion loan due 2025 has sunk to about 80
cents on the dollar, and Seadrill Operating LP, whose $2.6 billion loan
matu... 阅读全帖 |
|
C*******r
发帖数: 10345 | 41 别忘记，希特勒也是素食主义者：
Animal-Rights Activists Bully Dying Italian Girl
When 25-year-old veterinary student Caterina Simonsen posted an update on a
Facebook page supporting the use of animals in medical research before
Christmas, she was trying to say how lucky she felt to be alive. The Padua
native suffers from four rare genetic pulmonary diseases that require her to
use breathing tubes and experimental medication to thin the mucus in her
lungs in order to breathe. Her extreme illness makes her quic... 阅读全帖 |
|
a**********2
发帖数: 3726 | 42 医生是这个系统的最底层，完全是喝一点剩油的，真正控制这个系统的和吃大肉的是
pharmaceuticals, insurance companies, and lawyers. 并且医生说实在的赚的是卖
苦力的辛苦钱，收入还在受两面夹击，一面是政府(Medicare)和insurance companies
付费越来越少，另一方面是绝对收入没有提高但inflation与年俱增，相当于收入在走
低。因此就不要盯着医生那一点点可怜巴巴的血汗钱了，真正的利益阶层是那三个，
insurance companies, pharmaceutical, and lawyers.
Pharmaceuticals and insurance companies都是大的lobbyists and big donors to
both campaigns. 指望DC制定政策损害施主的利益？
Lawyers是制定法律的那一帮人，指望他们砸自己的饭碗？
医生是最没有说话权的，在这整个利益链上属于任人宰割的对象。 |
|
发帖数: 1 | 43 Joseph Jimenez
A drug patent lasts 20 years give or take.. This gives the inventors of the
drug time to capitalize on their drug and reap the rewards of their
innovations. Once their patent expires however, the drug is fair game.. This
allows generic companies to step in and produce the same drug, ultimately
reducing costs for consumers and making the drug cost-competitive. The
generic drugs must get approved by the FDA in order to start distribution.
What once was a well thought-out system has ... 阅读全帖 |
|
C******3
发帖数: 5 | 44 Sales Representative/Account Manager – Boston, MA
Location: Boston, MA
Req ID: S - BS - 002
Description:
Reports to: Regional Sales Manager
Department: Sales Department
As an Account Manager, your time and efforts will be focused on proactively
developing new customer accounts while supporting and growing an existing
customer base. You will be expected to sell and position BGI’s portfolio of
multi-omics services such as DNA sequencing, RNA sequencing, proteomics and
gene regulatory and epigeneti... 阅读全帖 |
|
p*********e
发帖数: 203 | 45 听系头说不只一个位置，帮忙宣传一下，有业内的同行可以转给你的朋友，学生和博厚
Assistant/Associate/Full Professor
The Department of Chemical Engineering at Auburn University invites
applications for a tenure-track faculty position beginning with the Fall
2016 semester. The individual selected for this position will be expected to
contribute to the growth of at least one of the department’s strategic
focus areas: energy and environment, advanced materials, computer-aided
chemical engineering, and pharmaceutical/biomedical engineering. ... 阅读全帖 |
|
b*****d
发帖数: 61690 | 46 http://stm.sciencemag.org/content/8/331/331ed3
Funding unfunded NIH research applications
The Biomedical Research Funding Enterprise Provides The Infrastructure that
leads to new medical products that impact global health. Throughout history,
the long and successful tradition in the United States of investing in
biomedical research involves funding support by government, nonprofit
biomedical foundations, pharmaceutical and biotechnology companies, and
other private funds. However, even with the ... 阅读全帖 |
|
p*********e
发帖数: 203 | 47 过去两年招了七个tenure track，两个lecturer。没想到今年还有，跟大家分享一下，
也请转给周围合适的朋友，谢谢。更新了一下，刚知道有两个位置。
Assistant/Associate/Full Professor: The Auburn University Department of
Chemical Engineering invites applications for multiple tenure track faculty
positions.
These tenure track appointments are to become effective in August 2017.
Our department seeks outstanding candidates who have a Ph.D. in chemical
engineering, petroleum engineering, or related field. The areas of expertise
are open; however the individuals selec... 阅读全帖 |
|
c*********o
发帖数: 1734 | 48 【 以下文字转载自 Pharmaceutical 讨论区 】
发信人: chinesegogo (gogo), 信区: Pharmaceutical
标 题: Job Opportunities
发信站: BBS 未名空间站 (Fri May 21 15:17:20 2010, 美东)
Please contact the rescruiter directly if you areinterested.
Christopher Corey
Search Group of San Diego
858-217-5582
c***[email protected]
bio/pharmaceutical organizations located in CA &MA.
(1) PRINCIPAL SCIENTIST. Deep knowledge in late stage formulation
development, controlled release drug delivery and solid dosage platforms.
(2) DIRECTOR OF FORMULATION |
|
c*********o
发帖数: 1734 | 49 【 以下文字转载自 Pharmaceutical 讨论区 】
发信人: chinesegogo (gogo), 信区: Pharmaceutical
标 题: Job opportunity
发信站: BBS 未名空间站 (Fri May 21 15:20:08 2010, 美东)
Please contact the recruiter directly if you are interested.
Rivka Spiegel
954) 720-9645 ext 139
(800) 958-2917 ext 139
r******[email protected]
Tarrytown, NY
A Ph.D. in pharmaceutics, biochemistry, chemistry or biology and minimum 5
years experience in the development of liquid and/or lyophilized protein
formulations, analytical development, and HPL |
|
j****n
发帖数: 429 | 50 【 以下文字转载自 Pharmaceutical 讨论区 】
发信人: jianan (JiaNan), 信区: Pharmaceutical
标 题: summer intern opportunity at GSK (philadelphia)
发信站: BBS 未名空间站 (Wed Feb 15 17:20:38 2012, 美东)
12-Week Summer Internship, Natural Language Processing and Text Mining
http://us.gsk.com/html/career/career-summer.html (search for requisition number: 73364)
GlaxoSmithKline (GSK) is a one of the world's largest pharmaceutical company
. We develop medicine and vaccines for both major disease areas including
asth... 阅读全帖 |
|
